Related Experiment Video
Updated: Apr 25, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Risk factors for venous thromboembolism in sickle cell disease
Neha Bhasin1, Li Zhang2, Ayotola Ajayi1
1Department of Pediatrics, University of California San Francisco, Oakland, California, USA.
Insights
Individuals with sickle cell disease (SCD) face a high risk of venous thromboembolism (VTE). Key risk factors include prior VTE or stroke, increased hospitalizations, smoking, central venous catheters, and hormonal therapy.
Area of Science:
- Hematology
- Vascular Medicine
- Thrombosis Research
Background:
- Sickle cell disease (SCD) significantly elevates the risk of venous thromboembolism (VTE).
- Understanding VTE risk factors and recurrence is critical for managing SCD patients.
Purpose of the Study:
- To identify risk factors associated with VTE development in individuals with SCD.
- To determine the recurrence rate of VTE events in this patient population.
Main Methods:
- Retrospective review of 719 patients with SCD from 2013-2023.
- Comparison of patients who developed VTE versus those who did not.
- Analysis of demographic and clinical data to identify risk factors.
Main Results:
- 8.9% of SCD patients experienced VTE, with deep vein thrombosis (61%) and pulmonary embolism (28%) being most common.
- Significant risk factors for VTE included prior VTE (OR 164), stroke (OR 39.8), and >=6 hospitalizations (OR 15.5).
- Smoking (OR 7.2), central venous catheter use (OR 6.9), and hormonal therapy (OR 9.6) were also associated with increased VTE risk. The VTE recurrence rate was 31%.
Conclusions:
- VTE risk in SCD is linked to a history of VTE or stroke, high healthcare utilization, central venous catheters, hormonal therapies, and smoking.
- The high recurrence rate highlights the need for improved VTE prevention and treatment strategies in SCD patients.
Background:
Individuals with sickle cell disease (SCD) have a high risk for venous thromboembolism (VTE).
Objectives:
To determine the associated risk factors and recurrence rate of VTE in SCD.
Methods:
We performed a retrospective review of 719 individuals with SCD followed at our institution between 2013 and 2023 and compared those who developed VTE with those who did not.
Results:
Of the 719 patients reviewed, 64 (8.9%) patients had 71 VTEs during the study period; 28% of the VTE events were pulmonary embolism and 61% were deep vein thrombosis. The odds ratio (OR) for developing a VTE was 164 (P < .001) for patients with a history of VTE, and the VTE recurrence rate was 31% during the study period. In addition, a history of stroke (OR, 39.8; P < .001) and a record of 6 or more hospitalizations in a 12-month period (OR, 15.5; P < .001) were significant risk factors for VTE in SCD. Other risk factors included smoking (OR, 7.2; P < .001), presence of a central venous catheter (OR, 6.9; P < .001), and use of hormonal therapy (OR, 9.6; P < .001).
Conclusion:
We conclude that the risk of VTE in SCD is associated with a history of VTE or stroke, increased health care utilization, use of CVCs, hormonal therapies, and smoking. The high VTE recurrence rate in this study suggests a need to better prevent and treat VTEs in individuals with SCD.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

